key: cord-0311211-mt7cg5bm
authors: Martín, Mariano; Modenutti, Carlos P.; Nicola, Juan P.; Marti, Marcelo A.
title: MotSASi: Functional Short Linear Motifs (SLiMs) prediction based on genomic single nucleotide variants and structural data
date: 2021-08-05
journal: bioRxiv
DOI: 10.1101/2021.08.05.455287
sha: b8a9ee46edd2d83876a362d7319b93dec68b0265
doc_id: 311211
cord_uid: mt7cg5bm

Short linear motifs (SLiMs) are key to cell physiology mediating reversible protein-protein interactions. Precise identification of SLiMs remains a challenge, being the main drawback of most bioinformatic prediction tools their low specificity (high number of false positives). An important, usually overlooked, aspect is the relation between SLiMs mutations and disease. The presence of variants in each residue position can be used to assess the relevance of the corresponding residue(s) for protein function, and its (in)tolerance to change. In the present work, we combined sequence variant information and structural analysis of the energetic impact of single amino acid substitution (SAS) in SLiM-Receptor complex structure, and showed that it significantly improves prediction of true functional SLiMs. Our strategy is based on building a SAS tolerance matrix that shows, for each position, whether one of the possible 19 SAS is tolerated or not. Herein we present the MotSASi strategy and analyze in detail 4 SLiMs involved in intracellular protein trafficking. Our results show that inclusion of variant and sequence information significantly improves both prediction of true SLiMs and rejection of false positives, while also allowing better classification of variants inside SLiMs, a results with a direct impact in clinical genomics.

Given their critical roles in cellular physiology, mutations disrupting SLiMs function lead to 119 several human diseases (Deretic et Martín et al., 2021a) . Where the SLiM is essential for the corresponding protein 121 function, motif disruption results in a non-functional protein and the observed phenotype is 122 similar to that observed for null mutations. Such is the case of mutation in the tyrosine-based 123 motif of the Low-density lipoprotein receptor (LDLR), where disruption of the motif conducts to 124 a deficient receptor internalization, leading to familial hypercholesterolemia (Etxebarria et al., 125 6 The relation between SLiMs mutations and disease, as will be shown in the present work, can 133 be used for two key developments, which indeed are two faces of the same coin. On one 134 hand, in the context of next generation based human sequencing for molecular diagnosis, it is 135 critical to determine whether a variant (mutation) found in a given patient is pathogenic (i.e 136 leads to disease development), or benign (has no effect). Although clinical criteria for 137 pathogenicity includes other properties (family segregation, relationship between observed 138 and expected phenotype, etc.) from a molecular viewpoint, they result from a significant 139 alteration of the corresponding protein function. Prediction of whether a particular variant 140 affects protein function is not straight forward for those resulting in Single Amino Acid 141 Substitutions (SAS), and there are many bioinformatic tools that perform this task ( proteins from 2 to 10 times. Moreover, in most of the cases, we discarded 10-20% of the 165 initially predicted motifs in the human proteome. The implementation of our MotSASi method 166 will significantly improve the prediction of biologically relevant motifs, thus avoiding the 167 experimental study of non-relevant motifs. 168

The results are organized as follows: First, we present the general aspects of our SLiMs 170 characterization pipeline, and analyze how the number of highly confident predicted SLiMs, 171 as well as the number of false positives evolve for all analyzed motifs. Second, using the 172 phospho-independent tyrosine-based motif, we show how SAS pathogenic-benign matrix 173 evolves as additional data and particular motifs are added. Finally, we show and discuss in 174 detail the results (newly identified proteins with high confidence SLiMs and the SAS 175 pathogenicity matrix) for all the analyzed motifs. 176

The process begins with a sequence based query of each motif in the whole human proteome, 178 consisting of all protein sequences annotated in the Homo sapiens genome in the UniProt 179 database, using regular expressions (for each motif regular expression see methods section) 180 (Fig 1 and Table 1 ). Identified putative motifs correspond to our Initial Set. Those motifs that 181 present at least one variant with Clinical Significance (ClinSig) or high Allelic Frequency (AF), 182 constitute our universe of analyzable motifs and were named Set 0 (S0). Subsequently, we 183 analyzed whether experimentally validated motifs (as reported in ELM database or 184 bibliography) were identified by our search and assigned them as Positive Set 0 (P0). As 185 shown in Table 1 , currently less than 3% of the potential motifs were experimentally validated, 186 underscoring the relevance of better identification tools. P0 corresponds to our initial positive 187 8 control group, and was used to determine: i) the degree of conservation, ii) the secondary 188 structure and iii) the position of the motif along the protein. Furthermore, using data from 189

ClinVar and GnomAD, we constructed two initial SAS matrices. One, with the clinical 190 significance of the variant [Pathogenic (P) or Benign (B)] which we will refer to as ClinSig 191 matrix, and the second with the allele frequency (represented as -log10(AF)), which we will 192 refer to as AF matrix. As expected, initial matrices contained several missing values (see S3, 193 S5 SAS if it is shown to occur in the context of the SLIMs but does not affect its function 206 significantly (i.e., a proxy for the underlying variants as being benign). To define a AF cut-off 207 value, we analyzed the -log10(AF) distribution (for visual and analyzable purpose we used the 208 -log10(AF), where low values of AF are represented as higher number in -log10(AF) and vice 209 versa) of pathogenic and benign variants in the whole human proteome (S1 Fig). Our data 210

shows that -log10(AF) of 4 is a good cut-off value. Therefore, we considered a variant with a 211 -log10(AF) < 4 as benign, while a value > 4 was considered as either pathogenic or benign. 212

With this information, we analyzed all S0 motif sequences (except those already in P0) and 213 classified them as either: Negative 1 (N1), S1 and P1 9

In this first filter, we dismissed the variants occurring at the flexible positions inside the motifs 215

(the x in the motif consensus sequence). N1 corresponds to those motifs from S0 which show 216 one (or more) variants assigned as bening (either directly from ClinVar and/or from AF 217 analysis) in a non tolerated position (in the SAS matrix), or as pathogenic (directly from 218 ClinVar) in a tolerated position. P1 corresponds to those potentially identified motifs which 219

show the presence of variants for which there is information in the SAS matrices, showing no 220 contradiction in their classification. In this case, the higher the number of known variants in 221 the potential motif whose characteristics agree with those of the P0, the higher the confidence 222 as a true SLiM. Finally, S1 are those remaining motifs for which no comparison could be 223 performed. 224

Set P1 was further refined using the motif conservation score, secondary structure, relative 225 position in the protein, and known protein localization filters. Those motifs from P1 whose 226 characteristics are not in accordance with those of experimentally tested motifs were moved 227 to N1. After filtering, the variants of the new predicted motifs (P1) were added to the ClinVar 228 and AF SAS matrices, and a new classification round was performed. We continued with this 229 iterative process until no changes were observed. These final, refined, sets are referred to as 230

N1f, S1f and P1f. 231

As already mentioned, SLiMs work by physically interacting with their protein receptors, and 232 thus SAS that hinder this interaction render the motif non functional. For many motifs, complex 233 structures between the receptor and either a small peptide including the SLiM, or the whole 234 protein harboring it, are available. To evaluate how the SAS in the motif affects protein-protein 235 interaction, we computed the change in the binding free energy (△△G) between wild type (or 236 reference) motif sequence and each possible SAS using the FoldX software. Thereafter, using structural information, we built for each motif and all possible SAS the 241 corresponding △△G matrix (see S3, S5 and S7 Figs), and used it to further classify the motifs 242 in S1f and P1f. 243

In a first step, we considered SAS matrix positions as non tolerant where △△G is higher than 244 2 kcal/mol and as tolerant those positions with △△G below 1 kcal/mol, and compared the 245 results with ClinSig and AF matrices. If no significant contradictions were evidenced, we 246 proceed to reclassify the motifs. Motifs in S1f which had variants assigned as Pathogenic or 247

Benign (from either ClinVar or AF), but couldn't be analyzed in the previous step due to a lack 248 of information, were now considered. Again, if a given motif SAS is classified as benign but in 249 a non tolerant position or pathogenic in a tolerant position, the motif is assigned to N2. While 250 if motif variants classification agree with the △△G matrix they are assigned to P2. Remaining 251 motifs, which could not be classified correspond to S2. As in the previous classification round, 252 the incorporation of new motifs to the positive control group allowed to iterate the process due 253 to the incorporation of new values to the ClinSig and AF matrices, leading to N2f, S2f and P2f. 254

In the next -final-step, we added to the analysis the flexible position of the motif and refined 255 those cases were the substitution has a moderate free energy change, defined as 1<△△G<2 256 kcal/mol. As for the other positions, we filtered the initially predicted motifs with this new 257 information, assigned them in either positive (P3) or discarded (N3) sets, and added this 258 information to build the definitive SAS tolerance matrix. With this new matrix we can determine 259 which SAS are tolerated or can lead to the motif disruption. Moreover, this matrix allows to 260 determine the flexibility of each position and consequently, better characterize the actual motif 261 consensus sequence. 262

Having described the general process we turn our attention to a particular case: the phospho-263 independent tyrosine based motif. 264 always located after a beta-extended structure forming a short helix or a loop where the 286 residues Asn and Tyr/Phe of the motif are located in pockets of the PTB domain (Fig 2A) . All 287 P0 proteins are localized in the plasma membrane or in the cytosol, the residues that constitute 288 the motif are highly conserved, the motif is preferentially located in the second half of the 289 protein, and in poorly structured or unstructured regions (Fig 2B-D) . 290

As previously described, using the P0 group we constructed the ClinSig and AF Matrices (Fig  291   3A and B), as well as the △△G matrix using the available crystal structures (Fig 3C) . 292

The first classification round (filtering matrix based on ClinSIg and AF data, Fig 4A) , allows to 293 discard 22 motifs (N1). As an example, we discarded the transmembrane protein 43 (Q9BTV4) 294 due to the presence of a Benign Tyr233Cys variant (rs35924492) in the predicted motif, which 295 has been reported as Pathogenic (Davis et al., 1986) . We also discarded the protein Pro-12 neuregulin-3 (P56975) since the variant Asn576Lys (rs17101193) has a -log10(AF) < 4, and 297 thus was considered Benign; however, positive charged residues at this position in the motif 298 have been reported as pathogenic (Fig 3) (Etxebarria et al., 2015) . This classification round 299 also results in 3 putative proteins that harbor a real tyrosine-based motif: Ephrin-B1 (P98172), 300 SCN1A (P35498) and HUWE1 (Q7Z6Z7). However, analysis of the data in the UniProt 301 database, allows discarding all three, thus moving them also to N1f,because P98172 and 302 P35498 have the motif in an extracellular domain, and Q7Z6Z7 resides in the nucleus. Neither 303 of these features is compatible with the nature of tyrosine-based motif (Bonifacino and Traub, 304 2003) . 305

Classification based on the structural-derived matrix (Fig 4B) , allows to discard 61 additional 306 motifs and moving them to N2, since for example Olfactory receptor 8J3 (Q8NGG0) presents 307 a Benign substitution Asn57Thr (rs1947924) but this change has an average △△G of 4.2 308 kcal/mol and so was considered disruptive. Similar reasons apply for the other cases. We 309 identified 3 proteins that may have a functional motif: DNAH12 (3rd motif) (Q6ZR08), TMCT4 310 (Q5T4D3) and GALAC1 (P07902). We discarded TMCT4 since it is an ER-resident protein 311 with the motif located in a luminal region. GALAC1 is a Galactose-1-phosphate 312 uridylyltransferase localized in the cytosol. All the features of the predicted motif in this protein 313 are in accordance to the positive control, and thus, we predict with high confidence that this 314 protein may have a functional tyrosine-based motif at the protein position 86-89. This region 315 of the protein is highly unstructured as revealed by the x-ray-solved 3D structure (McCorvie et  316 al., 2016). The mutations Y89H (rs111033666) and Y89D (rs111033666), that affect the 317 predicted tyrosine-based motif have been linked to Classical Galactosemia (Singh et al., 318 2012) . Clearly there are strong arguments as this being a functional motif. However, it is also 319 important to note that functional characterization of the Y89H mutant revealed that only 15% 320 of the protein activity is conserved, suggesting the substitution may affect protein stability 321 (Singh et al., 2012) . We analyzed the impact of both reported mutations at position Y89 to the 322 protein stability using FoldX, showing that both present values of > 6kcal/mol, thus also 323 suggesting that protein structure is affected. Therefore, although the data clearly shows that 324 13 mutations in this position are not tolerated, we cannot ascertain whether it is due to the 325 presence of a functional motif, due to production of an unstable protein, or both. Finally, the 326 protein DNAH12 has a Benign Tyr2740Phe variant (rs17057989) affecting the third predicted 327 tyrosine-based motif. This region of the protein is conserved and unstructured, in agreement 328 with the characteristics of a functional motif. Thereafter, we added it to the positive control 329 group. 330

Afterwards, we integrated the information of the flexible position and of some substitutions that 331

were not considered previously (refinement) in the next SAS tolerance matrix (Fig 4C) . With 332 this information, we discarded 27 additional motifs and we identified 44 new candidate motifs. We finally retained 10 proteins that may have real tyrosine-based motifs (Q8IX94, P0CG41, 341 Q13635, P26010 (2nd motif), Q9BSA4, Q5T7P8 (1st motif), Q9P2P5, Q9HAI6, Q14183, 342 Q8NHH9) and incorporated them in P3f. All of these show no contradiction and one variant 343 whose characteristics agrees with the tolerance matrix. The only protein that has more than 344 one variant congruent with the SAS tolerance matrix, and thus higher confidence is Q9BSA4. 345

Other minor points of note are protein E2 ubiquitin ligase HECW2 (Q9P2P5) which has a 346 pathogenic substitution Tyr1277His (rs1575255333) (flexible position of the motif) reported in 347

ClinVar, but there is no functional evidence that this mutation produces the disease, and the 348 integrin beta-7 (P26010) which has a phospho-dependent tyrosine based motif. In the last 349 step, we combined all the information to build the final SAS tolerance matrix (Fig 4D) . Finally, 350 we classified 158 motifs: 147 motifs are non-functional and 11 have high confidence of being 351 14 biologically relevant (S1 Table) . Only 2 motifs that present SAS with either ClinSig or -352 log10(AF)<4 could not be classified due to the lack of UniProt information. 353

The final SAS tolerance matrix serves three purposes. First, as shown by the previous filters, 354 it allows better prediction as to whether a given motif, found using regular expression, is (or 355 not) functional. Second, it delivers a more detailed description of the motif. In the present 356 example, the initial description of the Tyrosine-based motif is that it displays the form NPx To have a preliminary assessment of our proposed method capacity of detecting with high 396 confidence new (i.e previously unknown or non validated) motifs, we performed the following 397 analysis. From the 71 known PDZ binding motifs, we found 16 which have at least 1 variant 398 classified as pathogenic or benign due to its ClinSig or AF. We therefore divided these 16 399 motifs randomly in two parts and assigned one half to P0 and the other to S0. The P0 was 400 also complemented with the general information of the remaining positive motifs. 401

Subsequently, we applied the whole pipeline and looked at how many of the known motifs 402 assigned to S0 were retrieved in P3f. 403

Using the first P0 set, we were able to correctly predict all eight type 1 PDZ-binding motifs that 404 were experimentally validated. The true positive motifs were all predicted during the FoldX or 405 Flexible iteration step. Furthermore, with this (set 1) tolerance matrix we discarded 25 motifs 406 16 and predicted with high confidence 23 additional motifs (16 with low confidence) of being a 407 functional PDZ-binding motif. Using the second P0 set we were able to correctly predict 7 out 408 of 8 known type 1 PDZ-binding motifs. Again, for set 2, the true positive motifs were predicted 409 during the FoldX or Flexible iteration step. Also, we discarded 32 motifs and predicted with 410 high confidence 20 additional motifs (13 with low confidence). 411

The false negative corresponds to PDZ-binding motif (P43250), and is discarded due to the 412 reported Thr574Pro benign substitution (rs763634515), which our tolerance matrix assigns as or the substitution Ser4653Pro (rs748754632) of the Low-density lipoprotein receptor-related 420 protein 2 (P98164). In this scenario, we believe it is more likely that the variant is actually 421 pathogenic, despite its moderate frequency in one protein, and the tolerance matrix should 422

show Thr to Pro as a non tolerant SAS in the motif first position. In any case, and despite the 423 above mentioned detailed analysis, our preliminary cross validation showed that we were able 424 to retrieve 15/16 true motifs, which we consider a very good performance. 425

Taking these considerations into account and using the whole positive dataset, we discarded 426 22 motifs and predicted with high confidence 25 new motifs (S1 Table) . Furthermore, 18 motifs 427 show no SAS contradiction but lack UniProt information for assessing its biological relevance. 428

The final tolerance matrix (Fig 5A) After the iterative classification process, we were able to discard 102 motifs and identify 10 454 new high confidence potential candidates, and one additional potential motif which shows no 455 SAS contradiction, but lacks information in UniProt (S1 Table) . Analysis of the SAS tolerance 456 matrix (Figs 5B and S5) shows that the first position, in addition to L/M allows the presence of 457

Ile and perhaps even Pro. The third position, W which also seems to accept the other aromatic 458 residues (Y/F) and even Met. The fourth acid (D/E) position, possibly tolerates other polar 459 residues such as Asn, His or Tyr and some neutral residues such as Leu, Met or Phe. Finally, 460 the flexible position seems to tolerate well all residues except Pro. It should be noted however, 461 that the low amount of ClinSig variants makes these predictions to have moderate confidence. 462

Acidic di-Leucine motif 463 Leucine based motifs have been widely studied in intracellular trafficking, particularly in 464 polarized sorting and endocytosis (Bonifacino and Traub, 2003) . The nature of the residues in 465 the vicinity of the "di-Leucines'' determine the type of interaction that will take place. Acidic di- After the iterative classification process, we were able to discard 6285 motifs and identify 171 486 new high confidence potential candidates, 940 additional candidates lack information in 487 UniProt and therefore should be considered as awaiting further information (S1 Table) . 488 Surprisingly, the SAS tolerance matrix (Figs 5C and S7) shows that the first position seems to 489 not tolerate the presence of Arg, Asp, Thr and Trp, despite having Arg and Asp as part of the 490 consensus sequence. It should be noted however, that these results may be biased due to Angiotensin-converting enzyme 2 (ACE2) and some integrins (molecules that also act as 507 receptors of the virus) have been shown to contain many SLiMs mainly involved in endocytosis 508 (tyrosine-based motifs) and autophagy (LC3-interacting region motif) (Mészáros et al., 2021) . 509

On the other hand, disruption of the cellular protein network leads to improper cellular 510 functioning and therefore, to a disease development. SLiMs identification softwares usually 511 query protein sequences for the presence of motif consensus sequence or regular expression 512 pattern. Many use additional logical based filters, conservation scores and, more recently, 513

Hidden Markov models or machine learning techniques, in order to improve their predictability. 514 20 However, only a fraction of the predicted motifs are biologically relevant. Therefore, precise 515 functional SLiMs determination remains a challenge. In the present work, we show that motif 516 identification can be significanlty improved by the inclusion of information derived from 517 intraspecies variation, i.e human genome variant frequency and Clinical Significance, 518 combined with structure based interaction energy calculations between the SLiM and its 519 receptor. 520

For each SLiM we iteratively built a SAS tolerance matrix, which reflects in each motif position 521 whether a given substitution is tolerated or disruptive. We started by looking at ClinSig 522 information, and assumed that if a SAS in a previously established motif is shown to be 523 classified as clinically benign it should be tolerated and if classified as pathogenic it is not. As 524 shown in Table 1 , the number of true experimentally proved motifs with respect to those that 525 can be found using regular expressions is very small. Close, or even smaller than 1%. 526

Moreover, the number of motifs with reported variants in ClinVar is also very small, thus our 527 initial ClinSig matrices were almost empty. Inclusion of variant frequency information, 528 improved our tolerance matrices completeness, but still not enough. The key step, was to use 529 each motif-domain crystal structures to quantify each SAS △△G, and finally to add each new 530 high confident non contradictory motif information (ClinSig and AF) to the matrix. 531

At this point it is important to remark that obtention of a high confidence SAS tolerance matrix, 532 requires careful observation of positive feedback (i.e coincidence) of ClinSig, AF and FoldX 533 matrices, and resolution of those small number of positions which show conflicting 534 interpretations. For example, substitution tryptophan-acidic motif Leu at position 2, by Ile 535 shows a moderately high △△G value of 2.8 kcal/mol, which could indicate this change is not 536 tolerated. However, analysis of the AF of the corresponding variants undoubtedly classifies it 537 as benign, which together with analysis of the available information for those motifs displaying 538 this SAS confirms that the change is tolerated. Another, opposite example, is presented by 539 the PDZ-binding motif, and the case that leads to a false negative prediction when performing 540 the previously shown cross-validation. Here, the FoldX matrix shows that Thr to Pro 541 substitution is not tolerated. However, one protein with a functional motif shows this variant 542 with relative high AF, which could be classified as benign. Interestingly, in other proteins the 543 same variant displays significant lower AF, consistent with a non tolerable change. In this 544 case, our conclusion is that the SAS should be considered as non tolerable, and that the 545 variant is possibly pathogenic, even though it has a moderate AF. These examples underscore 546 the relevance of our strategy which combines the information for each SAS from three different 547 and independent sources (ClinSig, AF and Structure), and also suggests as key issues the 548 careful analysis of the final tolerance matrix to properly solve inconsistencies. 549

In addition to their predictive power (see below), obtention of the final SAS tolerance matrix 550 also results in a deeper understanding of the motif and its possible sequence variations. For 551 example, as seen for the phospho-independent tyrosine-based motif, the presence of His, Pro 552 or Phe at the flexible position seems to alter the motif recognition by its corresponding domain 553 ( Fig 4D) These results suggest that the consensus sequence of each motif should be re-considered 562 with corresponding impact in the universe of proteins that may have a functional motif. For 563 example, it is interesting to mention, that for some motifs, we found a discrepancy between 564 the final tolerance matrix and the regular expression (or consensus sequence). Particularly 565 the case of the acidic di-leucine motif where the first position has been proposed to tolerate 566 Glu, Asp, Gln and Arg, but our final tolerance matrix shows that neither Arg nor Asp can be 567 tolerated at this position (Fig 5C) , while other non-charged amino acids seems to be tolerated. 568

In this case, we believe that our results could be biased by the available crystal structures 569 used for the analysis where the motifs only contain Glu at the first position. In any case, the 570 22 point we want to make is that building the tolerance matrix and analysing it in the context of 571 the motif original regular expression, can help to refine the motif definition and thus its 572 subsequent searches in the protein universe. 573

Concerning our strategy, predictive capacity numbers are promising. Our preliminary 574 validation with Type-1 PDZ-binding motif showed that we could correctly retrieve 15 out of 16 575 true positive motifs. Generally speaking, in all cases we could identify a significant number of 576 novel motifs with high confidence, the numbers represent 2 to 10 times increase in the original 577 true positive set depending on the motif analyzed. Most importantly we were able to discard a 578 significant number of motifs, also with high confidence. We are able to classify with high 579 confidence all motifs included in the S0 set, i.e those where variants have been found (either 580 in ClinVar or in GenomAD). The S0 set currently represents 10-20% of the initial potential 581 motif set. However, as more and more human genomes and exomes are sequenced and 582 uploaded to public databases this number increases faster and faster. Therefore, our method 583 predictive capacity, both in terms of precision and number of motifs analyzed, also grows 584 continually. 585

Another point of notice, concerning future perspectives, concerns the current applicability 586 scope of the presented strategy. To apply our method, we need to: i) have an initial set of 587 known true positive (exp. validated) motifs (usually about 10) with ClinSig or AF information, 588

ii) have at least one crystal structure of the motif-receptor complex to build the FoldX matrix 589 and iii) have a moderately large set (over 100) of proteins harboring a potential motif with 590 reported variants (i.e S0). To have a preliminary assessment of the potential scope of the 591 presented method, we surveyed the whole ELM database. Our results (Table 2), show that in 592 addition to the presently analyzed motifs, there are 27 additional motif classes (out of 296) 593 that have at least 10 true human motifs, and at least one crystal structure of the motif-receptor 594 complex. By analyzing the number of motif-occurring variants we discarded 2 motifs due to 595 the lack of ClinSig variants in the motifs that constitute the positive control. Finally, 25 motifs 596 are clear candidates for near future application of the herein presented strategy. Moreover, it 597 is important to note that in our experience, manual literature search usually increases the 598

A method and server for predicting damaging missense mutations

Preferences Modulate Affinity and Selectivity among Five PDZ Domains that Bind CFTR

The MEME Suite

Mechanism underlying selective regulation of G protein-gated inwardly rectifying potassium 747 channels by the psychostimulant-sensitive sorting nexin 27

A Single Tyrosine Residue in the 750

Amyloid Precursor Protein Intracellular Domain Is Essential for Developmental Function

The Protein Data Bank

Templated Predictions of Novel Protein Interactions from Sequence Information

Signals for Sorting of Transmembrane Proteins to 757

Integrin cytoplasmic domain interactions 760 29 with phosphotyrosine-binding domains: A structural prototype for diversity in integrin 761 signaling

Predicting functionally important residues from sequence 763 conservation

Structural analysis 765 of phosphorylation-associated interactions of human MCC with Scribble PDZ domains

Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation 769 of engulfment adaptor PTB domain containing 1 threonine 35

Insights 771 into Kinesin-1 Activation from the Crystal Structure of KLC2 Bound to JIP3

mutation in familial hypercholesterolemia: Amino acid substitution in cytoplasmic 775 domain impedes internalization of LDL receptors

FoldX 5.0: working with RNA, small 777 molecules and a new graphical interface

Regulation of sorting and 779 post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA

Mammalian Numb Phosphotyrosine-binding Domain

A kinesin-1 binding motif in vaccinia 784 virus that is widespread throughout the human genome

Identification of Acidic Dileucine 786

Signals in LRP9 that Interact with Both GGAs and AP-1/AP-2

JPred4: a protein secondary structure 788 30 prediction server

Computational Prediction of Short Linear Motifs from Protein 790

A Conserved Sequence Motif in 792 the Integrin β3 Cytoplasmic Domain Is Required for Its Specific Interaction

Functional Characterization and Classification of Frequent Low-Density Lipoprotein 796

Receptor Variants

Basis for the Disruption of the Cerebral Cavernous Malformations 2 (CCM2) Interaction with 799

Krev Interaction Trapped 1 (KRIT1) by Disease-associated Mutations

Dab1-mediated colocalization of multi-803 adaptor protein CIN85 with Reelin receptors, ApoER2 and VLDLR, in neurons

Mechanism and role of PDZ domains in signaling complex 806 assembly

Disabled-1 Binds to the Cytoplasmic 808 Domain of Amyloid Precursor-Like Protein 1

Crystal structure of the human Scribble 810 PDZ 1 domain bound to the PDZ -binding motif of APC

Talin 812 phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell 813 migration

VMD: Visual molecular dynamics

Plasticity of PDZ domains in ligand recognition and signaling

Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin 820 adaptor protein complex 1

A novel D458V 823 mutation in the SANS PDZ binding motif causes atypical Usher syndrome

A structural 826 explanation for the binding of endocytic dileucine motifs by the AP2 complex

PSSMSearch: a server for modeling

proteome-wide discovery and annotation of protein motif specificity 830 determinants

ELM-the 833 eukaryotic linear motif resource in 2020

Structural basis of 836 CD4 downregulation by HIV-1 Nef

Cocrystal structure of the ICAP1 PTB domain in complex with a 838 KRIT1 peptide

Revealed by the Structure of Its PDZ12 Tandem in Complex with the Carboxyl Tail of Fras1

Minimotif Miner 843 4: a million peptide minimotifs and counting

The EMBL-EBI search and sequence analysis tools 846

APIs in 2019

Molecular Basis of the Interaction of the 849

Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-850 activated Protein Kinase p38γ

A Novel 853 SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid 854

A Carboxy-Terminal Monoleucine-Based Motif 857

Basolateral Targeting of the Na+/I− Symporter

The PDZ protein SCRIB regulates 861 sodium/iodide symporter (NIS) expression at the basolateral plasma membrane

Differential Distribution of Low-Density Lipoprotein-Receptor-Related Protein (LRP) and 864

Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate 868 uridylyltransferase

Short linear 871 motif candidates in the cell entry system used by SARS-CoV-2 and their potential 872 33 therapeutic implications

A Novel Claudin 16 Mutation Associated with Childhood Hypercalciuria Abolishes

Binding to ZO-1 and Results in Lysosomal Mistargeting

DILIMOT: discovery of linear motifs in proteins

Adaptor protein GULP is involved in stabilin-1-879 mediated phagocytosis

Structural Basis for Kinesin-881 1:Cargo Recognition

VarQ: A Tool for the Structural and Functional Analysis of 884

Interdomain interface-mediated target 886 recognition by the Scribble PDZ34 supramodule

How HIV-1 Nef hijacks the AP-2 clathrin 888 adaptor to downregulate CD4

Standards and guidelines for the 891 interpretation of sequence variants: a joint consensus recommendation of the American 892

Short Linear Motifs: Ubiquitous and Functionally Diverse Protein Interaction Modules

Directing Cell Regulation

The FoldX web 898 server: an online force field

PDZ Domains and the Organization of Supramolecular Complexes

PROSITE: A documented database using patterns and profiles as motif 902 descriptors

Biochemical and molecular characterization of 904

GALT gene from Indian galactosemia patients: Identification of 10 novel mutations and their 905 structural and functional implications

Selectivity and Phosphoinositide Binding Revealed by Structures of Disabled-1 PTB Domain 908

Interaction of CED-6/GULP, an Adapter Protein Involved in Engulfment of Apoptotic 911

Cells with CED-1 and CD91/Low Density Lipoprotein Receptor-related Protein (LRP)

UniProt: the universal protein knowledgebase in 2021

A Million Peptide Motifs for the Molecular 916 Biologist

Interaction of Cytosolic Adaptor 918

Structural 921 and evolutionary division of phosphotyrosine binding (PTB) domains

SIFT missense predictions for 923 genomes

2021. seaborn: statistical data visualization

Nesprins anchor kinesin-1 motors to the nucleus to drive 926 nuclear distribution in muscle cells

The structure of the harmonin/sans complex 928

reveals an unexpected interaction mode of the two Usher syndrome proteins

Molecular 931 Mechanism of Inward Rectifier Potassium Channel 2.3 Regulation by Tax-Interacting 932

Interaction between krit1 and 934 malcavernin

Crystallographic and Nuclear Magnetic Resonance Evaluation of the Impact of Peptide 937

Binding to the Second PDZ Domain of Protein Tyrosine Phosphatase 1E

Sequence-specific recognition of the internalization motif of the Alzheimer's 940 amyloid precursor protein by the X11 PTB domain

Molecular Basis for the 942

Recognition of Adenomatous Polyposis Coli by the Discs Large 1 Protein

Deciphering the 946

Unexpected Binding Capacity of the Third PDZ Domain of Whirlin to Various Cochlear Hair 947

Representative crystal structure of the type 1 PDZ-binding motig and PDZ domain complex

PDZ-domain is colored by residue type. (B). Box-plot showing the Jensenn-Shannon

Motif secondary structure prediction. : Beta-1004 sheet. : alpha-helix. C: Coil

Supplementary Figure 3. Type 1 PDZ-binding motif P0 SAS Matrices. (A) ClnSigMatrix

Pathogenic variants are presented in red palette and Benign in green palette. (B) AF Matrix

< 4 are colored in yellow and were considered as Benign. (C) △△G matrix 1009 (in kcal/mol). Values > 2 kcal/mol were considered as pathogenic

kcal/mol were considered as probably tolerated for the interaction

Representative crystal structure of the tryptophan-acidic motif and KLC-TPR domains 1014 complex. TPR-domains are colored by residue type. (B). Box-plot showing the Jensenn-1015

Histogram representing the distribution of the 1017 relative motif position with respect to the whole protein

Supplementary Figure 5. Tryptophan-acidic motif P0 SAS Matrices. (A) ClnSigMatrix

Pathogenic variants are presented in red palette and Benign in green palette. (B) AF Matrix

< 4 are colored in yellow and were considered as Benign. (C) △△G matrix 1022 (in kcal/mol). Values > 2 kcal/mol were considered as pathogenic

kcal/mol were considered as probably tolerated for the interaction

Supplementary Figure 6. Experimentally tested Acidic di-Leucine motifs. (A)

Representative crystal structure of the acidic di-leucine motif and sigma subunit complex

Sigma subunit is colored by residue type. (B). Box-plot showing the Jensenn-Shannon 1028

Histogram representing the distribution of the relative motif 1030 position with respect to the whole protein

 734 We acknowledge to Franco Brunello that assisted and discussed the initial project idea. 735 736

number of true positive motifs with respect to those reported in ELM and helps to refine the 599 motif Consensus Sequence, thus likely increasing method accuracy. 600Another potential source of seeds for our method is the Prosite database, which also presents 601 regular expression of motifs with the corresponding MSAs and identified human proteins. 602Although the present work was focused on motifs related to protein trafficking we expect to be 603 able to analyze its applicability to other types of motifs, such as those involved in post 604 translational modifications where the receptor is an enzyme and the motif key part of its 605 substrate. 606Finally, the proper constitution of motifs substitution matrices is also important for the 607 prediction of new Clinical Significance of variants occurring within the motif. According to our 608 analysis, over 70% of the SAS that can occur due to SNVs in a motif "rigid" position are 609 predicted to be disrupting and consequently, may lead to a pathogenic phenotype. If we add 610 the percentage of non tolerated SAS at the flexible position this percentage is still around ~40-611 50%. In other words, the reverse side of the coin, of using variant information to predict true 612 functioning motifs with high confidence, is the use of our knowledge of high confidence 613 identified motifs to better classify novel variants leading to SAS inside them. For a real working 614 example, consider that currently, ACMG guidelines assign PM1 (Pathogenic Moderate 1) to 615 those variants found in a well studied functional domain, without benign variants. If taken 616 strictly, most SAS inside SLiMs will not fulfill this criteria, since either the SLiM is not confirmed, 617 or even if its, as shown here, usually benign variants can be present, specially in the flexible 618 position. However, using our data, we could refine PM1 assignment when: i) the motif is 619 predicted as a high confidence motif and ii) the variant corresponds to a SAS in a non tolerated 620 position. Although other ACMG criteria are not as straightforward applicable to SLiMs, 621 knowledge of the presence or absence of a particular SLiM with high confidence and analysis 622 of a novel SAS in light of the final SAS tolerance matrix, definitely adds relevant information 623 for variant interpretation and classification, thus potentially leading to better diagnostics. 624Last but not least, we want to mention two current drawbacks of our proposed strategy. The 625 first, is that given that there is no ClinSig or AF information for non human species, our method 626 24 is restricted to human SLiMs. However, the rationale of the presented method could be 627 adapted to other species, provided experimental information akin to ClinSig or AF can be 628 produced, for example, using massive mutation selection experiments in microorganism 629 (bacteria, yeast) and/or using species (or higher taxa) population genetic data. 630Another drawback concerns the potential impact of SAS in regions adjacent to the SLiM that 631 significantly change its receptor recognition Accordingly, we recently showed that the variant 632 G561E in the sodium/iodide symporter, preceding a tryptophan-acidic sorting motif in the 633 carboxy-terminus of the transporter, shifts the equilibrium of the unstructured tryptophan-634 acidic motif towards a more structured conformation unrecognizable by KLC2, thus leading to 635 congenital hypothyroidism (Martín et al., 2021a) . Although our strategy currently is strictly 636 limited to SLiMs regular expression defined sequence, the same procedure can be extended 637 to adjacent residues, provided there is variant and structural information available. conservation score. The motif conservation score was calculated using the Jensen-Shannon 732 divergence as previously described (Capra and Singh, 2007